These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32097941)

  • 1. Membranous Nephropathy in Pregnancy.
    Liu ZN; Cui Z; He YD; Zhang YM; Wang F; Wang X; Meng LQ; Cheng XY; Liu G; Zhao MH
    Am J Nephrol; 2020; 51(4):304-317. PubMed ID: 32097941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.
    Sethi S; Debiec H; Madden B; Charlesworth MC; Morelle J; Gross L; Ravindran A; Buob D; Jadoul M; Fervenza FC; Ronco P
    Kidney Int; 2020 Jan; 97(1):163-174. PubMed ID: 31901340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against M-Type Phospholipase A2 Receptor May Predict Treatment Response and Outcome in Membranous Nephropathy.
    Qu Z; Zhang MF; Cui Z; Wang J; Wang M; Zhang YM; Wang F; Wang X; Meng LQ; Cheng XY; Liu G; Zhao MH
    Am J Nephrol; 2018; 48(6):438-446. PubMed ID: 30472708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
    Barrett C; Willcocks LC; Jones RB; Tarzi RM; Henderson RB; Cai G; Gisbert SI; Belson AS; Savage CO
    Nephrol Dial Transplant; 2020 Apr; 35(4):599-606. PubMed ID: 31243451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
    Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
    Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of serum anti-PLA2R levels and glomerular PLA2R deposits in primary membranous nephropathy.
    Chaitanya Gunda K; Mathew GG; Balasubramanian S; Sunil Kumar KS
    G Ital Nefrol; 2024 Apr; 41(2):. PubMed ID: 38695230
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
    Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A
    Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
    Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
    Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary membranous nephropathy in adolescence: A prospective study.
    Kumar V; Varma AK; Nada R; Ghosh R; Suri D; Gupta A; Kumar V; Rathi M; Kohli H; Jha V; Gupta K; Ramachandran R
    Nephrology (Carlton); 2017 Sep; 22(9):678-683. PubMed ID: 27334445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
    Hu R; Xing G; Wu H; Zhang Z
    Diagn Pathol; 2016 Sep; 11(1):86. PubMed ID: 27624606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
    Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
    Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
    Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
    Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of
    Guo Y; Guo N; Wang J; Wang R; Tang L
    Ren Fail; 2021 Dec; 43(1):729-736. PubMed ID: 33904354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.
    Burbelo PD; Joshi M; Chaturvedi A; Little DJ; Thurlow JS; Waldman M; Olson SW
    J Am Soc Nephrol; 2020 Jan; 31(1):208-217. PubMed ID: 31843984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis.
    Li W; Zhao Y
    Int Urol Nephrol; 2019 Sep; 51(9):1581-1596. PubMed ID: 31140029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.
    Teisseyre M; Cremoni M; Boyer-Suavet S; Crepin T; Benzaken S; Zorzi K; Esnault V; Brglez V; Seitz-Polski B
    Front Immunol; 2021; 12():738788. PubMed ID: 34721403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy].
    Lin W; Li H; Li X; Qin Y; Su Y; Yu Y; Guan Y; Duan L; Li Y; Wen Y; Li X
    Zhonghua Nei Ke Za Zhi; 2015 Sep; 54(9):783-8. PubMed ID: 26674797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.